Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Short-term Investments (2022 - 2024)

Select Medical Holdings (SEM) has disclosed Short-term Investments for 3 consecutive years, with $22.4 million as the latest value for Q2 2024.

  • For Q2 2024, Short-term Investments fell 73.28% year-over-year to $22.4 million; the TTM value through Jun 2024 reached $22.4 million, down 73.28%, while the annual FY2023 figure was $59.0 million, 21.23% down from the prior year.
  • Short-term Investments hit $22.4 million in Q2 2024 for Select Medical Holdings, down from $42.7 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $85.9 million in Q3 2023 and bottomed at $22.4 million in Q2 2024.
  • Average Short-term Investments over 3 years is $63.0 million, with a median of $72.1 million recorded in 2023.
  • Year-over-year, Short-term Investments fell 21.23% in 2023 and then plummeted 73.28% in 2024.
  • Select Medical Holdings' Short-term Investments stood at $74.9 million in 2022, then dropped by 21.23% to $59.0 million in 2023, then plummeted by 61.97% to $22.4 million in 2024.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $22.4 million, $42.7 million, and $59.0 million for Q2 2024, Q1 2024, and Q4 2023 respectively.